MedTrace Logo

Comparison of SBRTand Repeat TACE for HCC

NCT03326375 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-10-31

No results posted yet for this study

Summary

Comparison of Stereotactic Body Radiation Therapy (SBRT) and repeated transarterial chemoembolization (TACE) for Hepatocellular Carcinoma (HCC)as a Local Salvage Treatment after first incomplete TACE

Conditions

Interventions

RADIATION

SBRT

Maximum dose : 60Gray (Gy) Fraction : 2 to 5

Sponsors & Collaborators

  • Soonchunhyang University Hospital

    collaborator OTHER

  • Gangneung Asan Hospital

    lead OTHER

Principal Investigators

  • Gab Jin Cheon, M.D, Ph. D · University of Ulsan College of Medicine, Gangneung Asan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2020-03-31
Completion
2021-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03326375 on ClinicalTrials.gov